-

Agilent Announces Cash Dividend of 19.4 Cents per Share

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today announced that a quarterly dividend of 19.4 cents per share of common stock will be paid on Oct. 27, 2021, to all shareholders of record as of the close of business on Oct. 5, 2021.

The timing and amounts of future dividends are subject to determination and approval by Agilent’s board of directors.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets, delivering insight and innovation toward improving the quality of life. Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.34 billion in fiscal year 2020 and employs 16,400 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.

Forward-Looking Statements

This news release contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the safe harbors created therein. The forward-looking statements contained herein include, but are not limited to, information regarding the company’s dividend program and future payment obligations. These forward-looking statements involve risks and uncertainties that could cause Agilent’s results to differ materially from management’s current expectations. Such risks and uncertainties are detailed in Agilent’s filings with the Securities and Exchange Commission, including our quarterly report on Form 10-Q for the quarter ended July 31, 2021. Forward-looking statements are based on the beliefs and assumptions of Agilent’s management and on currently available information. Agilent undertakes no responsibility to publicly update or revise any forward-looking statement.

Contacts

Investor Contact:
Parmeet Ahuja
+1 408-345-8948
parmeet_ahuja@agilent.com

Media Contact:
Tom Beermann
+1 408 386 5892
tom.beermann@agilent.com

Agilent Technologies, Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Summary
Agilent announces dividend.
Release Versions
$Cashtags

Contacts

Investor Contact:
Parmeet Ahuja
+1 408-345-8948
parmeet_ahuja@agilent.com

Media Contact:
Tom Beermann
+1 408 386 5892
tom.beermann@agilent.com

Social Media Profiles
More News From Agilent Technologies, Inc.

Agilent to Announce Fourth-Quarter Fiscal Year 2026 Financial Results on Nov. 23

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results for the fourth quarter of fiscal year 2026 after the stock market closes on Monday, Nov. 23. The company will host a conference call to discuss the results at 1:30 p.m. PST the same day.To join the listen-only conference-call webcast, click the link on the Events section of Agilent’s Investor Relations website. A recording of the call will also be available on the website for 90 days.About Ag...

Agilent and University of Chicago Launch Center of Excellence for Energy Materials Research

SANTA CLARA, Calif. & CHICAGO--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A), a global leader in analytical and clinical laboratory technologies, and the University of Chicago, one of the world’s leading research universities, today announced a scientific collaboration to establish the Agilent Center of Excellence (CoE) for Energy Materials Research. The Agilent CoE will be based at the University of Chicago Pritzker School of Molecular Engineering (UChicago PME) and will support the Ene...

Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence

SANTA CLARA, Calif. & PHILADELPHIA--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Proscia®, a provider of digital pathology software for clinical and life-sciences customers, in an all-cash transaction valued at $240 million in cash at closing and up to an additional $30 million based on achieving future performance milestones. Proscia is a leading independent provider of enterprise digital pathology software, serving...
Back to Newsroom